News
Immunotherapy Research is Rebooting Seattle's Biotech Sector
Read More
News
Developing Disease-Modifying Therapies for Children with Type 1 Diabetes
Read More
News
One in Every Three People with Type 1 Diabetes Produces Insulin Years Post-Diagnosis
Read More
News
Learn about Immunotherapy and BRI's Work in Seattle Business Magazine
Read More
News
Food Allergy Development Linked to Skin Exposure - New Study from Steven Ziegler, PhD
Read More
News
BRI to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question
Read MorePress Release
Benaroya Research Institute to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question
Read More
News
BRI Receives $2.2 Million to Discover Biomarker that Triggers Allergies
Read MorePress Release
Benaroya Research Institute Receives $2.2 Million to Discover Biomarker That Triggers Allergies
Read More
News
Accelerator Corporation Secures $51.1 Million to Support Research
Read More
Press Release
Immune Tolerance Network’s TrialShare Recognized for Using Data for Public Good
Read More
Press Release
Benaroya Research Institute Scientists Identify Drivers of Rheumatoid Arthritis
Read More
News
Food Allergy Consortium (SeaFAC) to Bring New Research to the Northwest
Read MorePress Release
Research and Healthcare Organizations Form the Seattle Food Allergy Consortium (SeaFAC) to Bring New Treatments and Research to the Northwest
Read More
News
